, are at present not known. The identification of the molecular bases of such an overexpression, therefore, constitutes a topic of major interest.
A gene with a possible regulatory function with respect to c-myc expression has recently been hypothesised to map on chromosome 5. The functional loss, either by mutation or deletion, of this gene would allow the c-myc gene an uncontrolled transcriptional activity. This hypothesis follows from the observation that colorectal carcinomas which overexpress c-myc gene frequently display deletions of the long arm of chromosome 5 (Erisman et al., 1989) .
As previously demonstrated, however, two independent phenomena accounting for c-myc mRNA overexpression can occur separately or concomitantly in colorectal cancer. The first one is an 'apparent' c-myc overexpression, being substantially consequent to an increase in cell growth rate of the neoplastic tissue. Since c-myc expression is strictly associated with cellular proliferation, for every augmentation in cycling cell number of a tissue there is a proportional increase in c-myc mRNA level, in a context of unaltered c-myc transcriptional control mechanisms. This phenomenon occurs in about 70% of tumours. The second phenomenon is a real transcriptional deregulation of the c-myc gene where c-myc overexpression entity cannot be accounted for by a proportional augmentation in cell growth rate. This phenomenon, which can occur concomitantly with the first one, involves a subset comprising about 50% of the tumours (Table I) (Viel et al., 1990) .
On these grounds, we asked whether one of the two phenomona responsible for c-myc overexpression might significantly correlate with chromosome 5q deletions in colorectal cancers. DNA samples of Tumour/Normal tissue pairs from 22 colorectal cancer patients, heterozygous for the AMS8 probe, which maps on 5q34-qter region (Solomon et al., 1987) , were tested for Sq deletions by Southern blot analysis. Among them, four cases of Sq allelic loss were detected (C220, C229, C230, C244) ( Figure 1) , with a frequency (18%) in agreement with most previous reports (Solomon et al., 1987; Rees et al., 1989; Ashton-Rickardt et al., 1989) . The four tumours with 5q allelic deletion showed an increase in cell growth rate and a consequent 'apparent' c-myc overexpression, but only two of them (C220, C230) displayed a 'real' transcriptional deregulation of the gene (Table I ). The loss of 5q was, therefore, equally distributed among 'real' and 'apparent' c-myc overexpressing tumours.
The finding of chromosome 5 deletions in physiologically c-myc regulated tumours (C299, C244) seems to rule out a direct relationship between 5q deletion and c-myc gene transcriptional deregulation. On the other hand, 5q allelic deletions might be related to the increased cell growth rate of neoplastic tissue. The gene responsible for the Familial Adenomatous Polyposis (FAP) is located on chromosome 5 ac-myc overexpression entity was estimated as the ratio between c-myc mRNA level in tumour and corresponding normal colorectal mucosa. Two independent phenomena can account for the enhanced c-myc mRNA expression observed in neoplastic tissue: (1) increased cellular proliferation rate (see column b), (2) c-myc gene transcriptional deregulation (see column c) (Viel et al., 1990) . b Cellular hyperproliferation entity of the neoplastic tissue was estimated as the ratio between proliferative activity of the tumoural cell population relative to that of the corresponding normal one. This parameter has been evaluated on the basis of the S-phase specific histone H3 mRNA expression, which provides a good estimate of cell growth fraction (Baserga, 1981) . The ratio is indicative of the c-myc overexpression rate consequent to increases in cell growth fraction of neoplastic tissue. 'c-myc transcriptional deregulation rate of neoplastic tissue has been calculated as the ratio between c-myc mRNA overexpression (a) and cellular hyperproliferation entity (b). The ratio represents the c-myc overexpression rate not accounted for by increases in cell growth fraction of tumoural tissue.
Dash indicates c-myc transcriptional deregulation rates < 2. *Tumours with chromosome 5q deletion. Methods: Total cellular RNA was extracted from neoplastic and normal tissues by the guanidine chloride method (Cox, 1968) . c-myc and histone H3 mRNA expression levels were determined by densitometric scanning of both Northern and Dot blots, performed as described (Viel et al., 1990) . Figure 1 Loss of heterozygosity of chromosome 5 in informative colorectal tumours. DNA from matched tumour (T) and normal (N) pairs hybridised with AMS8 minisatellite probe, mapping on 5q34-qter region (Solomon et al., 1987) . Although allele loss is presumed to be complete in the tumour cells, being an early event (Vogelstein et al., 1988) , contamination of the sample with normal cells causes a reduction, rather than absolute loss of signal for one allele (Solomon et al., 1987) . In our cases, however, the contamination was usually less than 30%. Patients' numbers refer to Table I . C240 represents a control DNA. Methods: DNA extracted from tumour biopsies (T) and normal adjacent mucosa (N) was digested with Hinfl (New England Biolabs), electrophoresed on 0.8% agarose gels and blotted onto nylon membranes. AMS8 probe was oligo-labelled with a32P dCTP. Hybridisation and washing were by standard methods (Viel et al., 1990 ).
( Bodmer et al., 1987; Leppert et al., 1987) , in the same arm recognized by the AMS8 locus-specific hypervariable probe (Wong et al., 1987) . FAP is an autosomal dominant syndrome characterised by the development of hundreds of colorectal polyps that lead to the occurrence of frank carcinoma as early as 40 years of age (Bussey, 1975 (Vogelstein et al., 1988) . Similarly, also in the sporadic form of colorectal cancer, the somatic loss of one FAP allele might determine a promoting effect on cellular proliferation. In agreement with this hypothesis, all four tumours with 5q loss displayed an increased proliferative activity and consequently an 'apparent' c-myc overexpression, as compared to corresponding normal mucosa. Concerning the hyperproliferating carcinomas not displaying AMS8 allelic deletion (Table I) , the increase in cell growth rate might be due to genetic alterations affecting FAP gene, such as point mutations or interstitial deletions, not detectable by the experimental approach used.
In conclusion, our data do seem to indicate that chromosome 5q allelic deletion, by inducing a hyperproliferative condition of the neoplastic tissue, may be responsible for the genesis of an 'apparent' c-myc overexpression in human colorectal tumours.
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